CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

Stavudine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 14 USDMF, 1 CEP/COS, 2 EU WC, 4 NDC API, 1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers, 47 FDA Orange Book, 18 Europe, 21 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 9 DKSH, 3 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 2 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 12 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 15 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 27 Direct Compression, 24 Thickeners and Stabilizers, 16 Taste Masking, 15 Disintegrants & Superdisintegrants, 15 Granulation, 14 Coating Systems & Additives, 14 Co-Processed Excipients, 13 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 6 Controlled & Modified Release, 6 Parenteral, 6 Film Formers & Plasticizers, 5 Solubilizers, 4 Topical, 4 Rheology Modifiers, 3 Coloring Agents, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 Finished Drug Prices

9 Finished Drug Prices

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls download

Filters

List of Suppliers

Reset Filter

Price Info

Product Main Page

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/11/2024	Hetero Drugs	India	HETERO LABS LIMITED Hyderabad IN	R1-CEP 2008-162 - Rev 02	Stavudine	2017-08-10	Withdrawn by Holder	Chemical	2019-09-16	2130

Stavudine

Stavudine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

14 USDMF

1 CEP/COS

2 EU WC

4 NDC API

1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers

47 FDA Orange Book

18 Europe

21 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

13 SPI Pharma

9 DKSH

3 Faran Shimi Pharmaceutical

7 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

2 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

12 Kerry

1 Kima Chemical

3 Lonza Capsugel

13 Microlex e.U

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qualicaps

15 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

27 Direct Compression

24 Thickeners and Stabilizers

16 Taste Masking

15 Disintegrants & Superdisintegrants

15 Granulation

14 Coating Systems & Additives

14 Co-Processed Excipients

13 Lubricants & Glidants

11 Chewable & Orodispersible Aids

8 Empty Capsules

6 Controlled & Modified Release

6 Parenteral

6 Film Formers & Plasticizers

5 Solubilizers

4 Topical

4 Rheology Modifiers

3 Coloring Agents

2 Emulsifying Agents

1 API Stability Enhancers

1 Surfactant & Foaming Agents

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons